170 related articles for article (PubMed ID: 22115321)
1. Patterns of blood product use among patients with myelodysplastic syndrome.
Ramsey SD; McCune JS; Blough DK; McDermott CL; Beck SJ; López JA; Deeg HJ
Vox Sang; 2012 May; 102(4):331-7. PubMed ID: 22115321
[TBL] [Abstract][Full Text] [Related]
2. Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications.
Gupta P; LeRoy SC; Luikart SD; Bateman A; Morrison VA
Leuk Res; 1999 Oct; 23(10):953-9. PubMed ID: 10573142
[TBL] [Abstract][Full Text] [Related]
3. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of Transfusion Therapy Effectiveness in Patients with Myelodysplastic Syndrome].
Yin ZH; Pang ZR; Fang XC; Kong XJ; Yan C; He JJ; Xu J; Chen S; Zhu F; Chen Y; Tan QX; Gui L; Shi JN; Zhang HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1648-1653. PubMed ID: 33067968
[TBL] [Abstract][Full Text] [Related]
5. Incidence of myelodysplastic syndromes within a nonprofit healthcare system in western Washington state, 2005-2006.
De Roos AJ; Deeg HJ; Onstad L; Kopecky KJ; Bowles EJ; Yong M; Fryzek J; Davis S
Am J Hematol; 2010 Oct; 85(10):765-70. PubMed ID: 20815079
[TBL] [Abstract][Full Text] [Related]
6. RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis.
Zeidan AM; Zhu W; Stahl M; Wang R; Huntington SF; Giri S; Podoltsev NA; Gore SD; Ma X; Davidoff AJ
Leuk Lymphoma; 2019 Dec; 60(13):3181-3187. PubMed ID: 31170846
[TBL] [Abstract][Full Text] [Related]
7. Adverse impact of hyperferritinemia and transfusion dependency on treatment success in myelodysplastic syndrome.
Cakar MK; Yegin ZA; Baysal NA; Altındal S; Pamukçuoğlu M; Celik B; Yenicesu I
Transfus Apher Sci; 2013 Jun; 48(3):397-401. PubMed ID: 23619324
[TBL] [Abstract][Full Text] [Related]
8. Intensity of end-of-life care for patients with myelodysplastic syndromes: Findings from a large national database.
Fletcher SA; Cronin AM; Zeidan AM; Odejide OO; Gore SD; Davidoff AJ; Steensma DP; Abel GA
Cancer; 2016 Apr; 122(8):1209-15. PubMed ID: 26914833
[TBL] [Abstract][Full Text] [Related]
9. The burden of immune-mediated refractoriness to platelet transfusions in myelodysplastic syndromes.
Cheok KPL; Chhetri R; Wee LYA; Friel O; Pham A; Salvi A; McRae S; Bardy P; Singhal D; Roxby DJ; Wood EM; Hiwase DK
Transfusion; 2020 Oct; 60(10):2192-2198. PubMed ID: 32905635
[TBL] [Abstract][Full Text] [Related]
10. The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.
Buckstein R; Chodirker L; Yee KWL; Geddes M; Leitch HA; Christou G; Banerji V; Leber B; Khalaf D; St-Hilaire E; Finn N; Nevill T; Keating MM; Storring J; Parmentier A; Thambipillai A; Tang D; Westcott C; Cameron C; Spin P
Leuk Lymphoma; 2023 Mar; 64(3):651-661. PubMed ID: 36606533
[TBL] [Abstract][Full Text] [Related]
11. Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study.
Zhao J; Dahlén T; Edgren G
Vox Sang; 2021 May; 116(5):581-590. PubMed ID: 33210286
[TBL] [Abstract][Full Text] [Related]
12. Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes.
Zeidan AM; Wang R; Davidoff AJ; Ma S; Zhao Y; Gore SD; Gross CP; Ma X
Cancer; 2016 May; 122(10):1598-607. PubMed ID: 26970288
[TBL] [Abstract][Full Text] [Related]
13. Transfusion Support of Patients with Myelodysplastic Syndromes.
Guarente J; Tormey C
Clin Lab Med; 2023 Dec; 43(4):669-683. PubMed ID: 37865510
[TBL] [Abstract][Full Text] [Related]
14. Patient and physician perceptions about blood transfusions in the myelodysplastic syndromes.
King D; Schmidt R; Lesser M; Houk A; Salkeld E; Cogle CR
Leuk Res; 2020 Sep; 96():106425. PubMed ID: 32702549
[TBL] [Abstract][Full Text] [Related]
15. Red blood cell transfusion in myelodysplastic syndromes: A systematic review.
Kaka S; Jahangirnia A; Beauregard N; Davis A; Tinmouth A; Chin-Yee N
Transfus Med; 2022 Feb; 32(1):3-23. PubMed ID: 34927286
[TBL] [Abstract][Full Text] [Related]
16. Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes.
Moncharmont P; Quittançon E; Barday G; Benamara A;
Vox Sang; 2019 May; 114(4):349-354. PubMed ID: 30818416
[TBL] [Abstract][Full Text] [Related]
17. Physicians' experience in blood supply shortages and the top factors that impact the clinical, economic, and humanistic outcomes of patients with myelodysplastic syndromes in 5 European countries.
Gupta S; Kulasekararaj AG; Costantino H; Grisolano J; Tang J; Jones S; Tang D
Curr Med Res Opin; 2023 Feb; 39(2):239-247. PubMed ID: 36453466
[TBL] [Abstract][Full Text] [Related]
18. Iron status and treatment modalities in transfusion-dependent patients with myelodysplastic syndromes.
Delforge M; Selleslag D; Triffet A; Mineur P; Bries G; Graux C; Trullemans F; MacDonald K; Abraham I; Pluymers W; Ravoet C
Ann Hematol; 2011 Jun; 90(6):655-66. PubMed ID: 21318574
[TBL] [Abstract][Full Text] [Related]
19. Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population-based study.
Rozema J; van Roon EN; Kibbelaar RE; Veeger NJGM; Slim CL; de Wit H; Hoogendoorn M;
Transfusion; 2021 Oct; 61(10):2877-2884. PubMed ID: 34480360
[TBL] [Abstract][Full Text] [Related]
20. Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes.
Lin Y; Saskin A; Wells RA; Lenis M; Mamedov A; Callum J; Buckstein R
Vox Sang; 2017 Jan; 112(1):79-86. PubMed ID: 28097704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
